QUCHIC
QUCHMIC (named using EMCDDA naming standards but regularly mis-named QUCHIC), also known as BB-22, SGT-32 or QUinolin-8-yl 1-CycloHexylMethyl-1H-Indole-3-8-Carboxylate) is a designer drug offered by online vendors as a cannabimimetic agent, and was first detected being sold in synthetic cannabis products in Japan in early 2013, and subsequently also in New Zealand. The structure of QUCHMIC appears to use an understanding of structure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear.